Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32.4Revenue (TTM) $M5.3Net Margin (%)-359.5Altman Z-Score-17.7
Enterprise Value $M24.9EPS (TTM) $-1.0Operating Margin %-350.6Piotroski F-Score5
P/E(ttm)--Beneish M-Score3.7Pre-tax Margin (%)-359.4Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-191.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-708.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M30.3ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BIOC is held by these investors:

BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neff Edward A.Director 2016-10-19Buy227,272$1.1-2.73view
HALE DAVID FDirector 2016-10-19Buy90,909$1.1-2.73view
Nall Michael W.CEO & President 2016-10-19Buy36,363$1.1-2.73view
Chandler Marsha AlpertDirector 2016-10-19Buy4,545$1.1-2.73view
Kennedy TimothyCFO, Sr V.P. Operations & Sec. 2016-10-19Buy36,363$1.1-2.73view
HUEBNER BRUCE ADirector 2016-10-19Buy20,000$1.1-2.73view
Gerhardt BruceDirector 2016-10-19Buy50,000$1.1-2.73view
Singh VeenaSr VP & Sr Med Director 2016-10-19Buy10,000$1.1-2.73view
ARNOLD LYLE JSR VP of R&D and CSO 2016-10-19Buy45,000$1.1-2.73view
Wilson Margaret FayeDirector 2016-10-19Buy13,636$1.1-2.73view

Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Test Oct 18 2017 
    Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board Oct 11 2017 
    Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in Oct 03 2017 
    Biocept Launches Liquid Biopsy Test for NRAS Mutations Sep 05 2017 
    Biocept to Present at the 6th Annual Gateway Conference on September 6, 2017 in San Francisco Aug 28 2017 
    Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Aug 17 2017 
    Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR Aug 14 2017 
    Biocept Reports Second Quarter 2017 Financial Results Aug 10 2017 
    Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare M Aug 10 2017 
    Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage fo Aug 07 2017 
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat